SeaStar Medical Holding Corp [NASDAQ: ICU] stock went on a downward path that fall over -6.61% on Tuesday, amounting to a one-week price decrease of less than -1.98%. Over the last 12 months, ICU stock dropped by -77.67%. The one-year SeaStar Medical Holding Corp stock
SeaStar Medical Holding Corp [NASDAQ: ICU] gained 11.00% or 0.1 points to close at $1.01 with a heavy trading volume of 7907897 shares. The company report on March 12, 2024 at 8:30 AM that SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study
SeaStar Medical Holding Corp [NASDAQ: ICU] price plunged by -8.11 percent to reach at -$0.05. The company report on February 27, 2024 at 8:30 AM that Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in
SeaStar Medical Holding Corp [NASDAQ: ICU] plunged by -$0.34 during the normal trading session on while it closed the day at $0.77. The company report on February 22, 2024 at 7:58 AM that Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric
SeaStar Medical Holding Corp [NASDAQ: ICU] traded at a high on Friday, posting a 24.73 gain after which it closed the day’ session at $1.16. The company report on February 1, 2024 at 8:30 AM that SeaStar Medical Granted Canadian Patent with Broad Claims Covering
SeaStar Medical Holding Corp [NASDAQ: ICU] jumped around 0.04 points on Monday, while shares priced at $0.90 at the close of the session, up 4.66%. The company report on February 1, 2024 at 8:30 AM that SeaStar Medical Granted Canadian Patent with Broad Claims Covering
SeaStar Medical Holding Corp [NASDAQ: ICU] stock went on an upward path that rose over 1.99% on Wednesday, amounting to a one-week price increase of more than 2.68%. The company report on February 1, 2024 at 8:30 AM that SeaStar Medical Granted Canadian Patent with
SeaStar Medical Holding Corp [NASDAQ: ICU] loss -3.10% or -0.02 points to close at $0.82 with a heavy trading volume of 4246615 shares. The company report on January 26, 2024 at 8:05 AM that SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced
© 2024, Powered by Smart TechOne
